Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?
Levitsky J, Formica R. Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals? American Journal Of Transplantation 2017, 17: 2988. PMID: 28858416, DOI: 10.1111/ajt.14478.Peer-Reviewed Original Research